CVE-2012-6668: Multiple cross-site scripting (XSS) vulnerabilities in the Shout Reports in the DragonByte Technologies vBShou
CVE-2012-6668 is a medium-severity flaw (CVSS 6.1) affecting vbshout module. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Multiple cross-site scripting (XSS) vulnerabilities in the Shout Reports in the DragonByte Technologies vBShout module before 6.0.6 for vBulletin allow remote attackers to inject arbitrary web script or HTML via the (1) reportreason parameter in actions/doreport.php or (2) modnotes parameter in actions/updatereport.php.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 1.7% (top 23%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2018-01-11 |
| Last modified | 2026-06-16 |
Last updated 2026-06-16 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2012-6668?
vbshout module: upgrade to 6.0.6. Exact commands for each OS are on this page.
Is CVE-2012-6668 being exploited?
CVE-2012-6668 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2012-6668 affect?
CVE-2012-6668 affects vbshout module. Severity is medium (CVSS 6.1). Multiple cross-site scripting (XSS) vulnerabilities in the Shout Reports in the DragonByte Technologies vBShout module before 6.0.6 for vBulletin allow remote attackers to inject arbitrary web script or HTML via the (1) reportreason paramet
How urgent is CVE-2012-6668?
Priority 41/100. No elevated risk signals yet.